Healio Strategic Solutions’ New Advertising Products to Increase Audience Reach of Pharma Marketers
November 22, 2024
[Thorofare, NJ] November 2024 – Healio Strategic Solutions, a Wyanoke Group company, announces three new additions to its Advertising Solutions product suite: Clinical Insights Condition Center, Clinical Guidance: Monograph, and Clinical Guidance: Rare Diseases.
“Healio is rapidly evolving to offer pharmaceutical brands new strategic advertising solutions that can influence prescribers when they are making treatment decisions. These are the first of several new products that Healio is launching in the next several months,” said Anthony Manson, Chief Digital Officer of Healio.
Today’s healthcare professionals face information overload, rapid advancements in technology, and a challenging workload. They require efficient learning experiences to stay updated on developments in their field. Healio Clinical Insights Condition Center (CICC) features multimodal content based on the user’s preferred learning format that covers the latest news, perspectives, research, and clinical practices on a specific condition or area of interest. Pharma companies can reach CICC readers through onsite ads delivered to target list physicians. An exclusive editorial lock-up sponsorship opportunity, CICC advertising is a quick-to-market solution that enacts user-level targeting to strengthen brand awareness and interest.
Healio Clinical Guidance is a point-of-care tool with more than 20 modules on medical conditions to help physicians efficiently treat patients using reliable information. The modules were created by physician authors and contributors and feature a clinical overview alongside treatment and diagnosis information.
Healio Clinical Guidance: Monograph keeps physicians up to date on new treatment options. Pharma marketers can reach physicians at the point of prescribing through strategically placed banner and email ads containing vital clinical reference information. Healio Clinical Guidance: Rare Diseases educates physicians on the newest research and treatment methods surrounding a particular rare disease or condition. With 300 million people worldwide living with a rare disease, there is an urgent need for comprehensive information and resources. Health sciences companies can enhance physicians’ knowledge by advertising their solutions within a specialized context.
“We strive to create products that help pharma companies place important messages in front of physicians. We place an emphasis on innovation and are excited for our clients to take advantage of these new unique advertising opportunities,” said Christine Martynick, Senior Vice President, Advertising Solutions & Agency Partnerships at Healio Strategic Solutions.
To learn more about Healio Strategic Solutions’ Advertising, Deep Engagement, and Performance Solutions, visit HealioStrategicSolutions.com or contact Christine Martynick at [email protected].
###
About Healio
Healio is a multichannel information platform, providing health care specialists with tailored news, information and education in support of their daily practice of medicine. Healio’s core News, CME and Clinical Guidance channels deliver practical information and education across 21+ specialties. For more information, visit Healio.com.
###
About Healio Strategic Solutions
Healio Strategic Solutions (HSS) helps life sciences marketers reach healthcare professionals (HCPs) through our one-to-one relationship with the 3M+ HCPs on Healio’s platform. From educational activities to creative advertisements and advanced performance data, our clients’ content reaches broad and targeted audiences on the channels they use the most. For more information, visit Healio Strategic Solutions.com.
####